Cytokinetics, Inc. (CYTK)
76.76
-0.05
(-0.07%)
USD |
NASDAQ |
May 29, 14:05
Cytokinetics EPS Diluted (Quarterly) : -1.671 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BridgeBio Pharma, Inc. | -0.8422 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| BioMarin Pharmaceutical, Inc. | 0.5431 |
| Ionis Pharmaceuticals, Inc. | -0.5612 |
| Regeneron Pharmaceuticals, Inc. | 6.752 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -206.03M |
| Revenue (Quarterly) | 19.36M |
| Total Expenses (Quarterly) | 225.39M |
| Enterprise Value | 10.90B |
| Gross Profit Margin (Quarterly) | 69.36% |
| Profit Margin (Quarterly) | -1.06K% |
| Earnings Yield | -8.91% |
| Normalized Earnings Yield | -7.994 |